Results 251 to 260 of about 2,555,654 (307)

Evolution of CAR‐T Therapy: Functional Engineering, Manufacturing Innovation, and Future In Vivo Strategies

Cancer Science, EarlyView.
CAR‐T therapy is evolving across four interconnected dimensions: functional engineering, manufacturing innovation, alternative cell sources, and in vivo CAR programming. Together, these advances address limitations in therapeutic efficacy, safety, manufacturing complexity, scalability, and accessibility, providing complementary paths toward the next ...
Yukimi Sakoda
wiley   +1 more source

Editor's Note: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex. [PDF]

J Natl Cancer Inst
europepmc   +1 more source

Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib. [PDF]

Case Rep Hematol
Pelaez G, Yildiz BS, Candan M, Ismail M, Vacca F, Ruzinova MB, Ballentine S, Byrnes K, Ghobadi A.   +8 more
europepmc   +1 more source

Clonal and genomic determinants of e1a2 <i>BCR::ABL1</i> chronic myeloid leukemia: A Fi-LMC study. [PDF]

Hemasphere
Podvin B, Nibourel O, Hayette S, Coiteux V, Kim R, Rigolot L, Dulucq S, Boudry A, Pawlak G, Lambert WC, Flandrin-Gresta P, Sloma I, Roumier C, Balsat M, Loron S, Li C, Geffroy S, Cayuela JM, Huguet F, Mahon FX, Nicolini FE, Réa D, Preudhomme C, Duployez N, Roche-Lestienne C, Fi‐LMC group.   +25 more
europepmc   +1 more source

A Current Overview of Quality-of-Life Research in Chronic Myeloid Leukemia (CML). [PDF]

Cancers (Basel)
Deneberg S.
europepmc   +1 more source

Imatinib Resistance in Chronic Myeloid Leukemia Is Associated with Distinct Metabolic, Oxidative, and Autophagic Adaptations in K562-Derived Cell Sublines. [PDF]

Biomedicines
Rachid E, Lahmouad M, Bellemrrabet R, Aboussaleh Y, Amahdar L, Abboussi O.   +5 more
europepmc   +1 more source

“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”.

, 1998
active member, [. . . ], CANTONETTI, MARIA, By The Italian Cooperative Study Group on Chronic Myeloid Leukemia, DAMIANI, Daniela, Cantonetti, M, Italian Cooperative Study Group on Chronic Myeloid Leukemia, [...]   +7 more
core  

Effectiveness and Safety of Imatinib and Nilotinib in Chronic Myeloid Leukemia: A Single-Center Study From Southern Morocco. [PDF]

Cureus
El Mousadik M, El Khayat H, El Hizazi L, Bounar O, Halloumi O, Fatima Ezzahra R, Chakri I, Bouqoufi A, Lahlou L, Fares S.   +9 more
europepmc   +1 more source

Chronic Myeloid Leukemia: Historical Perspective, Pathophysiology, and Treatment Advances.

Acta Haematol
Tungjitviboonkun S, Daran L, Unsuwan S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic Myeloid Leukemia

New England Journal of Medicine, 1999
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles Sawyers
exaly   +3 more sources